These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8588030

  • 1. Superparamagnetic nanoparticles as blood-pool contrast agents. Contribution to MRI preclinical investigations.
    Benderbous S, Bonnemain B.
    Radiologe; 1995 Nov; 35(11 Suppl 2):S248-52. PubMed ID: 8588030
    [No Abstract] [Full Text] [Related]

  • 2. Experimental investigation of the delivery pathway of ultrasmall superparamagnetic iron oxide to lymph nodes.
    Frija G, Clément O, Le Guen O, Cuénod CA, Siauve N, Benderbous S.
    Acad Radiol; 1996 Aug; 3 Suppl 2():S299-300. PubMed ID: 8796586
    [No Abstract] [Full Text] [Related]

  • 3. Magnetic resonance lymphography. Enhancement patterns using superparamagnetic nanoparticles.
    Clément O, Guimaraes R, de Kerviler E, Frija G.
    Invest Radiol; 1994 Jun; 29 Suppl 2():S226-8. PubMed ID: 7928239
    [No Abstract] [Full Text] [Related]

  • 4. [Overview of MRI contrast media. The case of endorem].
    Duroux M.
    Radiologe; 1995 Nov; 35(11 Suppl 2):S247-8. PubMed ID: 8588029
    [No Abstract] [Full Text] [Related]

  • 5. MR lymphography: evidence of extravasation of superparamagnetic nanoparticles into the lymph.
    Clement O, Rety F, Cuenod CA, Siauve N, Carnot F, Bordat C, Siche M, Frija G.
    Acad Radiol; 1998 Apr; 5 Suppl 1():S170-2; discussion S183-4. PubMed ID: 9561073
    [No Abstract] [Full Text] [Related]

  • 6. [Use of ultrasmall ferric oxide (Sinerem) particles as a magnetic resonance contrast substance for imaging lymph nodal metastases in cancer of the head and neck].
    Sviridov NK, Napolov IuK, Bolotova EN, Iakobs LV.
    Vestn Rentgenol Radiol; 2004 Apr; (3):63-4. PubMed ID: 15587888
    [No Abstract] [Full Text] [Related]

  • 7. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
    Taupitz M, Wagner S, Hamm B, Binder A, Pfefferer D.
    AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
    [Abstract] [Full Text] [Related]

  • 8. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.
    Briley-Saebo K, Bjørnerud A, Grant D, Ahlstrom H, Berg T, Kindberg GM.
    Cell Tissue Res; 2004 Jun; 316(3):315-23. PubMed ID: 15103550
    [Abstract] [Full Text] [Related]

  • 9. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients.
    Barentsz JO, Fütterer JJ, Takahashi S.
    Eur J Radiol; 2007 Sep; 63(3):369-72. PubMed ID: 17689215
    [Abstract] [Full Text] [Related]

  • 10. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model.
    Sigovan M, Boussel L, Sulaiman A, Sappey-Marinier D, Alsaid H, Desbleds-Mansard C, Ibarrola D, Gamondès D, Corot C, Lancelot E, Raynaud JS, Vives V, Laclédère C, Violas X, Douek PC, Canet-Soulas E.
    Radiology; 2009 Aug; 252(2):401-9. PubMed ID: 19703881
    [Abstract] [Full Text] [Related]

  • 11. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.
    Islam T, Wolf G.
    Cancer Biomark; 2009 Aug; 5(2):69-73. PubMed ID: 19414923
    [Abstract] [Full Text] [Related]

  • 12. Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond.
    Anzai Y.
    Top Magn Reson Imaging; 2004 Apr; 15(2):103-11. PubMed ID: 15269613
    [Abstract] [Full Text] [Related]

  • 13. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits.
    Clarke SE, Weinmann HJ, Dai E, Lucas AR, Rutt BK.
    Radiology; 2000 Mar; 214(3):787-94. PubMed ID: 10715047
    [Abstract] [Full Text] [Related]

  • 14. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
    Taupitz M, Schnorr J, Abramjuk C, Wagner S, Pilgrimm H, Hünigen H, Hamm B.
    J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
    [Abstract] [Full Text] [Related]

  • 15. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.
    Guimaraes R, Clément O, Bittoun J, Carnot F, Frija G.
    AJR Am J Roentgenol; 1994 Jan; 162(1):201-7. PubMed ID: 8273666
    [Abstract] [Full Text] [Related]

  • 16. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Montie JE.
    J Urol; 2005 Sep; 174(3):870-1. PubMed ID: 16093977
    [No Abstract] [Full Text] [Related]

  • 17. Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON).
    Korosoglou G, Tang L, Kedziorek D, Cosby K, Gilson WD, Vonken EJ, Schär M, Sosnovik D, Kraitchman DL, Weiss RG, Weissleder R, Stuber M.
    J Magn Reson Imaging; 2008 May; 27(5):1175-80. PubMed ID: 18425827
    [Abstract] [Full Text] [Related]

  • 18. Application of superparamagnetic iron oxide (AMI-227) for 3D phase-contrast MR angiography.
    Tanimoto A, Yuasa Y, Hiramatsu K.
    Acad Radiol; 1998 Apr; 5 Suppl 1():S113-5. PubMed ID: 9561058
    [No Abstract] [Full Text] [Related]

  • 19. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10.
    Harisinghani MG, Dixon WT, Saksena MA, Brachtel E, Blezek DJ, Dhawale PJ, Torabi M, Hahn PF.
    Radiographics; 2004 Apr; 24(3):867-78. PubMed ID: 15143236
    [Abstract] [Full Text] [Related]

  • 20. Investigation of atherosclerotic plaques with MRI at 3 T using ultrasmall superparamagnetic particles of iron oxide.
    Priest AN, Ittrich H, Jahntz CL, Kooijman H, Weber C, Adam G.
    Magn Reson Imaging; 2006 Dec; 24(10):1287-93. PubMed ID: 17145399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.